These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16311269)

  • 1. Genetics of Parkinson's disease: LRRK2 on the rise.
    Brice A
    Brain; 2005 Dec; 128(Pt 12):2760-2. PubMed ID: 16311269
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease: the LRRK2-G2019S mutation: opening a novel era in Parkinson's disease genetics.
    Bonifati V
    Eur J Hum Genet; 2006 Oct; 14(10):1061-2. PubMed ID: 16835587
    [No Abstract]   [Full Text] [Related]  

  • 3. Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.
    Berg D; Schweitzer KJ; Leitner P; Zimprich A; Lichtner P; Belcredi P; Brüssel T; Schulte C; Maass S; Nägele T; Wszolek ZK; Gasser T
    Brain; 2005 Dec; 128(Pt 12):3000-11. PubMed ID: 16251215
    [No Abstract]   [Full Text] [Related]  

  • 4. LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.
    Krüger R
    BMC Med; 2008 Nov; 6():33. PubMed ID: 18986509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine-rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian.
    Carmine Belin A; Westerlund M; Sydow O; Lundströmer K; Håkansson A; Nissbrandt H; Olson L; Galter D
    Mov Disord; 2006 Oct; 21(10):1731-4. PubMed ID: 16817197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.
    Civitelli D; Tarantino P; Nicoletti G; Cirò Candiano IC; Annesi F; De Marco EV; Carrideo S; Rocca FE; Condino F; Spadafora P; Pugliese P; D'Asero S; Morelli M; Paglionico S; Annesi G; Quattrone A
    Clin Genet; 2007 Apr; 71(4):367-70. PubMed ID: 17470139
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of LRRK2 and GBA mutations in a Brazilian family with Parkinson's disease.
    Spitz M; Pereira JS; Nicareta DH; Abreu Gde M; Bastos EF; Seixas TL; Pimentel MM
    Parkinsonism Relat Disord; 2015 Jul; 21(7):825-6. PubMed ID: 25952961
    [No Abstract]   [Full Text] [Related]  

  • 9. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.
    Lesage S; Dürr A; Tazir M; Lohmann E; Leutenegger AL; Janin S; Pollak P; Brice A;
    N Engl J Med; 2006 Jan; 354(4):422-3. PubMed ID: 16436781
    [No Abstract]   [Full Text] [Related]  

  • 10. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
    Gosal D; Lynch T; Ross OA; Haugarvoll K; Farrer MJ; Gibson JM
    Mov Disord; 2007 Jan; 22(2):291-2. PubMed ID: 17089395
    [No Abstract]   [Full Text] [Related]  

  • 11. How much does dardarin contribute to Parkinson's disease?
    Brice A
    Lancet; 2005 Jan 29-Feb 4; 365(9457):363-4. PubMed ID: 15680438
    [No Abstract]   [Full Text] [Related]  

  • 12. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews.
    Ozelius LJ; Senthil G; Saunders-Pullman R; Ohmann E; Deligtisch A; Tagliati M; Hunt AL; Klein C; Henick B; Hailpern SM; Lipton RB; Soto-Valencia J; Risch N; Bressman SB
    N Engl J Med; 2006 Jan; 354(4):424-5. PubMed ID: 16436782
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation.
    Giordana MT; D'Agostino C; Albani G; Mauro A; Di Fonzo A; Antonini A; Bonifati V
    Mov Disord; 2007 Jan; 22(2):275-8. PubMed ID: 17149743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common LRRK2 mutation in idiopathic Parkinson's disease.
    Gilks WP; Abou-Sleiman PM; Gandhi S; Jain S; Singleton A; Lees AJ; Shaw K; Bhatia KP; Bonifati V; Quinn NP; Lynch J; Healy DG; Holton JL; Revesz T; Wood NW
    Lancet; 2005 Jan 29-Feb 4; 365(9457):415-6. PubMed ID: 15680457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of Parkinson disease: to test or not to test.
    Suchowersky O
    Can J Neurol Sci; 2007 Aug; 34(3):266-7. PubMed ID: 17803021
    [No Abstract]   [Full Text] [Related]  

  • 17. A trojan horse for Parkinson's disease.
    Hu Y; Tong Y
    Sci Signal; 2010 Apr; 3(116):pe13. PubMed ID: 20371768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
    Di Fonzo A; Rohé CF; Ferreira J; Chien HF; Vacca L; Stocchi F; Guedes L; Fabrizio E; Manfredi M; Vanacore N; Goldwurm S; Breedveld G; Sampaio C; Meco G; Barbosa E; Oostra BA; Bonifati V;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):412-5. PubMed ID: 15680456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advance of the study on LRRK2 gene in Parkinson's disease].
    Zhang Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):657-9. PubMed ID: 19065525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.